Shared compound evidence record
Tirzepatide (20mg)
Weight Management
In Stock
Tirzepatide
40mg Lyophilised Powder
$249.99AUD per vial
1
Concentration
40mg
Category
Weight Management
Volume Savings
Express shipping available Australia-wide
No published analytical document is currently linked
Availability
Ready to purchase now
In stock now and ready for checkout.
Next business day dispatch cutoff
Order within the current dispatch window
Melbourne cut-off time updates live every second.
Time Remaining
19:13:24
Purchase Other Quantities
Tirzepatide is listed in two vial sizes. Compare the current formats below and choose the quantity that fits your research workflow.
Frequently Bought Together
Stable research navigation
Connected catalogue records
These links are based on catalogue family, evidence records, research topics and bundle composition. They do not imply therapeutic similarity.
Connected compound evidence
Retatrutide (10mg)
Weight Management
Connected compound evidence
Retatrutide (20mg)
Weight Management
Connected compound evidence
Retatrutide (30mg)
Weight Management
Connected compound evidence
Tesamorelin (10mg)
Weight Management
Connected compound evidence
Retatrutide Starter Bundle
Weight Management
Research library
Evidence and analytical context for this record
These resources separate compound identity, batch-quality questions and study evidence. A linked study does not establish that this catalogue material is equivalent to a medicine or investigational product.
Product Information
Tirzepatide (40mg) — Extended Dual-Incretin Research Format
Tirzepatide is a synthetic peptide that activates both GIP and GLP-1 receptors, providing a dual-pathway model for studying incretin biology. The larger 40mg format is suited to extended analytical workflows and multi-stage experimental designs.
Key Research Areas
- Dual-Receptor Signalling — Comparative study of combined GIP and GLP-1 receptor activity
- Glucose Homeostasis — Investigation of glucose-dependent insulin signalling and glycaemic-response pathways
- Appetite Biology — Models involving satiety signalling and gastric-emptying mechanisms
- Adipose Metabolism — Research into insulin sensitivity, lipid handling and body-composition pathways
- Incretin Comparisons — A dual-agonist reference for comparison with single- and triple-receptor compounds
Supplied as a nominal 40mg lyophilised research powder. Batch-specific analytical documentation will be published in our CoA Library when available, with fast domestic shipping across Australia.
For in-vitro research and laboratory use only. Not for human or veterinary use or consumption.
Frequently Asked Questions
What is Tirzepatide (40mg)?
Tirzepatide (40mg) is the larger research format of the dual GIP and GLP-1 receptor agonist. It contains the same compound as the 20mg listing and is intended for extended in-vitro workflows or multi-stage experimental designs.
How does the 40mg format differ from Tirzepatide 20mg?
The peptide and receptor profile are the same in both formats. The 40mg vial provides twice the nominal quantity, while the 20mg format is suited to smaller research runs.
Which pathways are studied with Tirzepatide?
Tirzepatide is studied as a dual-incretin research compound across GIP and GLP-1 receptor signalling, glucose-dependent insulin response, satiety pathways, gastric-emptying mechanisms and adipose metabolism.
How do you reconstitute Tirzepatide?
Tirzepatide is supplied as a lyophilised powder and should be prepared with an appropriate laboratory-grade solvent under controlled research conditions. Follow the study protocol, batch documentation and institutional handling requirements.
Where to buy Tirzepatide 40mg in Australia?
Tirzepatide (40mg) is listed by AUS Peptide Supply with domestic shipping to all Australian states and territories. Current availability is shown live on this page, and batch documentation will appear in our CoA Library when available.
What is the availability and cost of Tirzepatide 40mg?
Tirzepatide (40mg) is currently in stock at AUS Peptide Supply and available for domestic dispatch across Australia. Tirzepatide (40mg) is priced at $249.99 AUD per vial at AUS Peptide Supply. All orders ship domestically within Australia, and batch CoAs are available in our CoA library.